Abstract:In this viewpoint, we argue for the importance of creating data spaces for genomic research that are detached from contexts in which fundamental rights concerns related to surveillance measures override a purpose-specific balancing of fundamental rights. Genomic research relies on molecular and phenotypic data, on comparing findings within large data sets, on searchable metadata, and on translating research results into a clinical setting. These methods require sensitive genetic and health data to be shared across borders. International data sharing between the European Union (EU) or the European Economic Area and third countries has accordingly become a cornerstone of genomics. The EU General Data Protection Regulation contains rules that accord privileged status to data processing for research purposes to ensure that strict data protection requirements do not impede biomedical research. However, the General Data Protection Regulation rules applicable to international transfers of data accord no such preferential treatment to international data transfers made in the research context. The rules that govern the international transfer of data create considerable barriers to international data sharing because of the cost-intensive procedural and substantive compliance burdens that they impose. For certain jurisdictions and select use cases, there exist practically no lawful mechanisms to enable the international transfer of data because of concerns about the protection of fundamental rights. The proposed solutions further fail to address the need to share large data sets of local and regional cohorts across national borders to enable joint analyses. The European Health Data Space is an emerging federated, EU-wide data infrastructure that is intended to function as an infrastructure bringing together EU health data to improve patient care and enable the secondary use of health-related data for research purposes. Such infrastructure is implementing new institutions to support its functioning and is being implemented in reliance on a new enabling law, the regulation on the European Health Data Space. This innovation provides the opportunity to facilitate EU contribution to international genomic research efforts. The draft regulation for this data space provides for a concept of data infrastructure intended to enable cross-border data exchange and access, including access to genetic and health data for scientific analysis purposes. The draft regulation also provides for obligations of national actors aimed at making data widely available. This effort is laudable. However, in the absence of further, more fundamental changes to the manner in which the EU regulates the secondary use of health data, it is reasonable to believe that EU participation in international genomic research efforts will remain impeded.

European health regulations reduce registry-based research

European Health Regulations Reduce Registry-Based Research

The European Health Data Space: Too Big To Succeed?

Ethical and social reflections on the proposed European Health Data Space

Enhancing the reuse of health data for research purposes: laws and regulations as pillars of trust

Collaboration in Healthcare: Implications of Data Sharing for Secondary Use in the European Union

Bridging the European Data Sharing Divide in Genomic Science

Secondary Use of Health Data: Centralized Structure and Information Security Frameworks in Finland

A critique of the regulation of data science in healthcare research in the European Union

Toward the European Health Data Space: The IMPaCT-Data secure infrastructure for EHR-based precision medicine research

The impact of the General Data Protection Regulation on health research

European Health Data Space—An Opportunity Now to Grasp the Future of Data-Driven Healthcare

Big Tech platforms in health research: Re-purposing big data governance in light of the General Data Protection Regulation’s research exemption

Prerequisites for International Exchanges of Health Information: Comparison of Australian, Austrian, Finnish, Swiss, and US Privacy Policies

Expanding citizen engagement in the secondary use of health data: an opportunity for national health data access bodies to realise the intentions of the European health data space

Public consultation for European health data space is open

Who owns (or controls) health data?

A review of attitudes towards the reuse of health data among people in the European Union: The primacy of purpose and the common good

Reflections on the Data Governance Act

Reconciling the biomedical data commons and the GDPR: three lessons from the EUCAN ELSI collaboratory

A reference architecture for personal health data spaces using decentralized content-addressable storage networks